John Poyhonen

2019 - Heron Therapeutics

In 2019, John Poyhonen earned a total compensation of $4.5M as Executive Vice President, Chief Commercial Officer at Heron Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$90,751
Option Awards$4,211,063
Salary$216,731
Other$6,219
Total$4,524,764

Poyhonen received $4.2M in option awards, accounting for 93% of the total pay in 2019.

Poyhonen also received $90.8K in non-equity incentive plan, $216.7K in salary and $6.2K in other compensation.

Rankings

In 2019, John Poyhonen's compensation ranked 2,531st out of 13,971 executives tracked by ExecPay. In other words, Poyhonen earned more than 81.9% of executives.

ClassificationRankingPercentile
All
2,531
out of 13,971
82nd
Division
Manufacturing
912
out of 5,695
84th
Major group
Chemicals And Allied Products
295
out of 2,194
87th
Industry group
Drugs
237
out of 1,880
87th
Industry
Pharmaceutical Preparations
174
out of 1,392
88th

Pay ratio

John Poyhonen's Pay$4,524,764
Median Employee's Pay$408,623
Pay Ratio

11

to 1

In 2019, the annual total compensation of John Poyhonen was $4,524,764.

The annual total compensation of the median employee at Heron Therapeutics was $408,623.

The ratio of John Poyhonen's pay to the pay of median employee was therefore 11 to one.

Source: SEC filing on April 23, 2020.

Poyhonen's colleagues

We found four more compensation records of executives who worked with John Poyhonen at Heron Therapeutics in 2019.

2019

Barry Quart

Heron Therapeutics

Chief Executive Officer

2019

Kimberly Manhard

Heron Therapeutics

Executive Vice President, Drug Development

2019

Robert Hoffman

Heron Therapeutics

Chief Financial Officer

2019

Robert Rosen

Heron Therapeutics

Former President

News

In-depth

You may also like